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Abstract
The air-liquid interface filled with pulmonary surfactant is a unique feature of our lung alveoli.
The mechanical properties of this interface play an important role in breathing and its malfunction
induced by an environmental hazard, such as ozone, relates to various lung diseases. In order to
understand the interfacial physics of the pulmonary surfactant system, we employed a microfluidic
bubble generation platform with a model pulmonary surfactant composed of two major
phospholipids: DPPC (1,2-dipalmitoyl-sn-phosphatidylcholine) and POPG (1-palmitoyl-2-oleoyl-
sn-phosphatidylglycerol). With fluorescence imaging, we observed the ozone-induced chemical
modification of the unsaturated lipid component of the lipid mixture, POPG. This chemical change
due to the oxidative stress was further utilized to study the physical characteristics of the interface
through the bubble formation process. The physical property change was evaluated through the
oscillatory behaviour of the monolayer, as well as the bubble size and formation time. The results
presented demonstrate the potential of this platform to study interfacial physics of lung surfactant
system under various environmental challenges, both qualitatively and quantitatively.
Introduction
In recent years, microfluidics has been demonstrated as a powerful and practical tool for
generating microdroplets and microbubbles.1–3 Due to their small size, highly reproducible
formation process and controllability, microdroplets are utilized in various applications,
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including the encapsulation and reaction of bio-components, such as proteins,4–6 DNAs2 and
cells.7,8 Microbubbles, however, have been utilized mainly as medical imaging contrast
agents and studies have focused more on how to generate microbubbles in a controllable and
high throughput manner.9,10 Studying the interfacial physics through the bubble generation
process has recently been the major study topic rather than applications.11–14 Here, however,
we focus on the characteristic of the air–liquid interface in a new application using the
formation process of microbubbles, as well as their physical properties.
The air–liquid interface is an interesting topic in fundamental physics, but it also plays an
important role in biology. One of the major examples is the cardiopulmonary system. The
cardiopulmonary system is constantly exposed to airborne environmental hazards. The
short- and long-term exposure of lungs to irritants, such as pathogens and air pollutants, can
cause acute and chronic injuries.15–17 Such exposures occur at the air–liquid interface of the
pulmonary surfactant (PS) system, which provides the first barrier of our lungs to an
environmental challenge. The PS is a mixture of lipids and proteins that participates in the
breathing cycle, but also prevents lung collapse by reducing the surface tension of the
alveolar sacs. Thus, the physical and chemical characteristics of the interfacial PS system are
of high interest. Microbubbles are a valuable tool for this application because they can be
modified to resemble a PS interface. Microbubbles can also provide a platform for the
detailed investigation of interfacial dynamics.11–14
We demonstrate an application of microbubbles, controlled within microfluidic systems,
towards understanding the physical properties of alveolar sacs, especially under oxidative
stress. Ozone has been reported as a representative source of air pollution that is associated
with the risk of death from respiratory illness.15 Several groups have reported on the
influence of ozone-induced oxidative stress on the chemistry of the air–liquid interfacial PS,
and have found that this exhibits characteristics that are distinct from the solution
phase.18–20 The above cited investigations focused on selective molecular transformations
that occur as a result of oxidative stress only at the interface. Such molecular
transformations can have a strong influence on the physical properties of the PS system (e.g.
the surface tension and elasticity of the PS interface), and so understanding how chemical
transformations influence such physical properties can provide key insights into how the PS
system responds to environmental challenges. For this purpose, we employed a microfluidic
bubble generation platform with a model PS system composed of two major phospholipids:
DPPC (1,2-dipalmitoyl-sn-phosphatidyl choline) and POPG (1-palmitoyl-2-oleoyl-sn-
phosphatidyl glycerol), which is exposed to the condition of normal air and air containing
~20 ppm ozone.
Experimental methods
Design and fabrication of the microfluidic device
The microfluidic device was fabricated with PDMS (polydimethylsiloxane, Silgard 184,
Dow Chemical, MI, USA) by standard soft lithography.21 SU-8 (MicroChem, MA, USA)
patterned wafer was used as a mold to cast PDMS into the microchannel device. The
microfluidics design was based on a flow focusing device (FFD)22 combined with a straight
channel perpendicular to the bubble formation component. The height and width of the main
channel were both 200 μm, and the narrow channel for bubble generation was 60 μm.
Detailed design parameters can be found in Fig. S1.† The PDMS was solvent extracted just
prior to bonding in order to prolong its hydrophilicity following plasma treatment.23 The
molded PDMS and a bare glass slide were both treated with oxygen plasma and bonded
together to form the completed microfluidics chip. The microchannels were filled with water
immediately following the bonding step in order to further maintain hydrophilicity of the
surface.22
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Bubble formation tests and analysis
Sodium salts of DPPC (1,2-dipalmitoyl-sn-phosphatidylcholine), POPG (1-palmitoyl-2-
oleoyl-sn-phosphatidylglycerol) and NBD-PG (1-oleoyl-2-[12-[(7-nitro-2-1,3-
benzoxadiazol-4-yl)amino]dodecanoyl]-sn-glycerol-3-[phospho-rac-(1-glycerol)]) were
purchased from Avanti Polar Lipid (Alabaster, AL). Nitrobenzoxadiazole (NBD) is a widely
used fluorophore that has an excitation at 470 nm and an emission at 540 nm.24 The lipid
sample was prepared by mixing 20 μM DPPC and 20 μM POPG in 1 × PBS solution. The
sample solutions with small unilamellar vesicles (SUVs) were prepared by a number of
freezethaw cycles. The hydrated lipid solution is then extruded through 100 nm
polycarbonate membrane filters at room temperature. The average size of the SUV is
measured as 62(±25) nm using the dynamic light scattering method. The parameters for the
bubble generation were optimized for ambient (including standard atmospheric air
composition) conditions. The microfluidic device, as well as the gas and liquid introduction
systems, is shown in Fig. 1. A syringe pump (Fig. 1A) was utilized to flow the lipid sample
into the device at a constant flow rate of 7 μl min–1. The air or air/ozone mixture was
injected at a constant pressure, 0.42 psi. Ozone was generated by a pencil-style UV
calibration lamp (model 6035, Oriel) that was placed upstream of the pressure regulator. By
turning on the UV lamp, air flow was converted to ozone flow. Ozone concentration was
measured spectrophotometrically and maintained at 20 ppm.
The bubble formation process was monitored by a brightfield microscope (Nikon Eclipse
TE2000) throughout the experiments (Fig. 1B and 1C) and recorded as a movie at 30 frames
s–1 by a CCD camera. All of the images were extracted from the movie by DVDVideoSoft
(DVDVideoSoft.com) and analyzed by ImageJ (NIH) for the size and the generation time of
bubbles. The formation time for the first thirteen bubbles was measured for the analysis. For
the bubble size analysis, the length of the bubbles was measured for the first fifteen bubbles.
All experiments were performed at room temperature.
Analysis and imaging of the ozone effect
To visualize the ozone effect at the interface, fluorescently tagged PG lipid (NBD-PG) was
added to the lipid sample. The lipid sample composition was 20 μM DPPC, 10 μM POPG
and 10 μM NBD-PG in 1 × PBS solution. The same flow condition as for the bubble
formation test was used for monitoring the fluorescence using confocal microscopy (Nikon
E800) for the air, as well as the ozone conditions. Images were averaged over 10 frames for
visualization. Gray-scale intensity was measured with ImageJ.
Results and discussion
The experimental setup, device design and bubble formation process are shown in Fig. 1.
The bubble generation device comprises three inlet channels: a center channel supplying gas
and two outer channels supplying the lipid mixture in solution. Constant inflow of the gas
and lipids mixture led to the generation of highly reproducible bubbles through a pinch-off
process (Fig. 1C). Bubbles were generated with a polydispersity index of ~1%
(supplementary Table 1†). The polydispersity index is defined as the standard deviation of
the length of the bubble divided by the mean length of the bubble in percentage. The low
polydispersity index demonstrates the consistency of bubble generation in the device,
allowing us to obtain statistically meaningful results. Also, these microbubbles can be a
good model for more in-depth understanding of the system owing to its air–liquid interface
nature and to the similar size to the alveoli (100–300 μm). Since the bubble generation
process is very sensitive to physical conditions, monitoring the bubble size and frequency of
the bubble generation process became the main emphasis of this paper. This will link the
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chemical compositional changes to the physical characteristics of the interface, giving a
complete understanding of a model PS system.
Most commonly used microfluidic devices for bubble generation are based on two
geometries: T junction13,25 and flow focusing device (FFD).14,22 Our design is mostly based
on FFD, but also has a T junction-like characteristic due to the perpendicular main flow
channel to the bubble formation components (Fig. S1 and S5†). In that design, we can think
of three major factors that influence bubble formation: the pressure force from gas, the shear
stress induced by flow and the elastic property of the lipid monolayer (Fig. S5†).12 The gas
pressure and flow rates are fixed so the observed changes in bubble formation are associated
with ozone exposure, and are induced by the influence of the ozone on the physical
characteristics (interfacial tension or elasticity) of the lipid monolayer.
In order to validate the potential of our system in studying the interface, we performed a test
to confirm the chemical compositional change at the interface under ozone exposure through
visualization. We have previously demonstrated the heterogeneous ozonolysis of a mixture
of saturated and unsaturated phospholipids at the air–liquid interface using field-induced
droplet ionization mass spectrometry (FIDI-MS).20 We found that only the unsaturated
phospholipids react with ozone, forming relatively hydrophilic products, such as aldehydes
and carboxylic acids. Within 30 s of formation, these products dissolve into the bulk phase,
leaving only saturated phospholipid on the surface of the droplet. To confirm this chemistry
in our system, we used a fluorescently tagged unsaturated lipid, NBD-PG along with the
model PS system, a mixture of DPPC and POPG. For microbubble experiments, a constant
flow of a lipid mixture of DPPC, POPG and NBD-PG was maintained in the microfluidic
device and either air or ozone was introduced to generate bubbles. A distinct fluorescence
signal was observed in the liquid phase near the interface when ozone was introduced (Fig.
2), indicating the formation and the dissolution of hydrophilic products of NBD-PG
ozonolysis into the aqueous solution around the interface. This visual detection of the
chemical change of the unsaturated lipid components presents the potential of microbubbles
by confirming our previous finding.20 To make sure that the ozonolysis of NBD-PG doesn't
significantly affect the result obtained in Fig. 2, we performed two ozonolysis product
analyses with electrospray ionization mass spectrometry (ESI-MS): one for the mixture of
DPPC, POPG and NBD-PG and the other for NBD-PG only (Fig. S2–S3†). The results
show that the NBD-PG produces similar hydrophilic products to POPG in the mixture. It is
notable that low abundant products from the ozonolysis of NBD-tag are also observed in the
MS spectra (Fig. S2†). However, the reaction rate of ozonolysis of the probe is relatively
lower than that of a C–C double bond due to its delocalization property.26 In addition, the
NBD-tag loses its intrinsic fluorescence property due to the decomposition of the conjugated
ring. Hence, it is hard to expect that there is significant bias to the fluorescence image in Fig.
2 from the ozonolysis of NBD-tag (Fig. S4†). Since DPPC and POPG represent major
components of saturated and unsaturated phospholipids, respectively, in our lung pulmonary
surfactant system, it is interesting to see physical, as well as chemical property changes of
the air–liquid interface induced by environmental stress, such as ozone. DPPC is known as
the principal phospholipid component with very low surface tension upon compression27,28
and POPG is known to improve the adsorption and spreading of surfactant owing to their
higher fluidity.29,30 Thus, dissolving POPG into the bulk solution from the interface can
change the physical characteristics of the interface, which relates to the lung physiology and
disease. It is also notable that the increase in ozone concentration is associated with a higher
fatality rate from respiratory illness.15 In that sense, it is necessary to study the physical
characteristics of our lung surfactant system under environmental challenges.
To achieve this goal, we move on to investigate the change of bubble formation processes,
which represents physical characteristics of the interface, caused by the chemical
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composition alteration in a mixed lipid surfactant layer of DPPC and POPG due to the
oxidative stress by ozone. The tip of the interface near the bubble formation region oscillates
significantly until the bubble is ejected to the flow (Fig. 3A, 3B and supporting movie 1 and
2†). However, a significant difference was observed in a bubble formation process with
ozone compared to air. Fig. 3B shows the time-lapsed trajectories of the lower tip of the
interface until bubbles were formed. Stronger oscillation was observed for the case of air
compared to the case of ozone. The oscillatory characteristic indicates that the elastic
property of the interface is different between air and ozone conditions. To further analyze
this, we can consider the effective elastic modulus (Eeff) defined as
(1)
Under the assumption that the interface near the bubble formation region (in the thread) can
be simplified as a cylinder (Fig. S5†), we can expect the following force balance at
equilibrium based on the free body diagram (Fig. S5B†),
(2)
where Fp, Fs and Fk are pressure force, shear force and restoring elastic force, respectively.
Using Fp = pπr2 and Fk = kΔx, eqn (2) becomes,
(3)
where k is the spring constant of the monolayer, Δx is transverse displacement, p is the
applied pressure and r is the radius of the cylinder. Then,
(4)
where L is the initial length of the cylinder in the thread. In the equilibrium condition, we
can assume a harmonic oscillatory motion and the harmonic approximation leads to Fk =
kΔx = m(2πf)2Δx, where m is the mass of the oscillating body and f is the oscillation
frequency. From eqn (3) and (4), the effective elastic modulus can be expressed as
(5)
Assuming that low concentration of ozone (~20 ppm) does not change the density of the
working gas, Eeff becomes a function of the oscillation amplitude and the frequency.
Analysis on our data in Fig. 3B shows that Eeff at the interface, when ozone is applied, is
~28% higher compared to the case of air. Numerical values used for the calculation can be
found from the supplementary Table 2†. Thus, it appears that oxidation leads to a higher
concentration of DPPC (and lower concentration of POPG) at the interfacial surfactant layer,
which in turns yields a more elastic (i.e. resistant to deformation) interface. This increase in
the elastic constant is likely primarily due to the reduced fluidity of the saturated lipids
relative to the unsaturated ones, POPG. Based on an analogy with a deformation process of a
material under increasing tensile stress, the bubble formation process is similar to reaching
the ultimate tensile strength (UTS). Thus, it is also interesting that we observed the
increased time required for bubble formation (Fig. 3C) in the presence of ozone. This means
that the ozone changes the material property of the interface, which is what we found out
from the chemical analysis.
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Bubble size is another metric for the physical property of the lipid surfactant layer. In Fig. 4,
representative pictures of bubbles (A) and the averaged bubble sizes (B) are presented. The
bubble size is smaller when ozone is the working gas. We also observed a decrease in
bubble size when the mole fraction of POPG decreases to 10% of DPPC in the lipid mixture
(Fig. S6†). We can think of a simple scaling of the bubble size as Garstecki et al. has
reported previously:12,22Vb ∝ qaτ, where Vb is the volume of the bubble, qa is the rate of
inflow gas, and τ is the time that the thread stays open until the bubble is ejected into the
flow. Since τ is inversely proportional to the elasticity, we can expect that high elasticity
induces shorter τ that reduces the volume of the bubble. This agrees well with our
observation of increased Eeff and reduced size resulting from the increase of DPPC mole
fraction in the surfactant layer following the heterogeneous ozonolysis of POPG. In addition
to the effect of elasticity of surfactant layer, we can also examine the dynamic viscosity of
the interface when the surfactant composition changes. The Hagen–Poiseuille relation, qa ∝
p/μ and τ ∝ 1/q leads to Vb ∝ p/qμ where μ is the dynamic viscosity and q is the volume
flow rate of the solution. Since p and q are fixed in our experiment, we can compare the
dynamic viscosity for both conditions simply by measuring bubble size. From the measured
bubble scale, we found that the dynamic viscosity of the surfactant layer was increased by
~4.4% when ozone was used compared to pure air for bubble formation. This analysis
shows that the bubble formation process is very sensitive to the alterations of the lipid
compositions in the surfactant layers and has a potential for the analytical tool to study the
interface physics.
Conclusions
We have developed a microfluidic bubble generator that enables the analysis of physical
property changes in a model pulmonary surfactant layer at the air–liquid interface under
oxidative stress condition. The chemical composition change of the phospholipid mixture
under oxidative stress in the air–liquid interface was identified visually through fluorescence
monitoring. Chemical compositional changes induce a model PS lipid monolayer under
oxidative stress to become more elastic and increase dynamic viscosity of the surfactant
layer. We observed their effects in terms of the bubble size and the oscillatory formation
process. Ozone exposure is known to affect breathing and pulmonary functions, including
alteration of the respiratory rate, decrease of tidal volume and airflow limitation.31–34 The
observed chemical composition changes followed by physical property alterations may play
a critical role in such symptoms. Also in the PS system, regulating the surface viscosity by
condensing or removing unsaturated lipids has been reported as an important role for SP-C,
one of the lung surfactant specific proteins, to prevent lung dysfunction. Thus, a lack of one
of the major components of the PS system, such as POPG as we studied, can be a potential
source of lung damage over time.35 Our platform was validated for its potential use in
studying the physical characteristics of the interface resulting from chemical reactions at the
interface. Due to the sensitive response, reproducibility for good statistics and the ease of
manipulation/analysis, we believe that microbubbles in microfluidics have a potential in
understanding the interfacial physics, as well as chemistry of the various surfactant systems.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Fig. 1.
(A) The experimental setup for the bubble generation and ozone effect test. (B) The
microfluidic device design for the bubble generation and the zoomed-in image of the bubble
formation component. Air or ozone was injected from the center channel and lipid mixture
was flowed from the outer two channels. The width of the narrow thread channel is 60 μm
and the main flow channel for bubbles is 200 μm. (C) Representative pictures of the bubble
formation process. Bubbles are generated through a pinch-off process in a reproducible
manner. The dark regions around the air–liquid interfaces are due to the contrast difference
originating from the 3D curvature of the interface. All scale bars: 200 μm.
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Fig. 2.
The effect of ozone on the chemical composition change in the interface. (A) 10 frames
averaged fluorescence images for air (left) and ozone (right) conditions. When ozone is the
working gas, accumulated hydrophilic products of NBD-PG showed stronger fluorescence
in the bulk phase near the interface. The dark regions around the air–liquid interfaces are
due to the contrast difference originating from the 3D curvature of the interface. Scale bar:
100 μm. (B) Line profile of the gray scale intensity along the yellow lines in (A).
Fluorescence intensity of the ozone condition showed about a two-fold increased value near
the interface.
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Fig. 3.
(A) Snap shots of the bubble formation component after 10 frames (0.33 s) from the
previous bubble formation. (B) Time-lapsed trajectories of the lower end point of the
interface. Stronger oscillation for a shorter time period was observed when air was the
working gas. (C) The required time for the bubble formation. The averaged time for the
fifteen bubbles is shown.
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Fig. 4.
Bubble size analysis. (A) Representative images of the bubbles in different conditions.
Pictures were taken when bubbles flowed 20 mm downstream from the bubble formation
component. Scale bar: 200 μm. (B) Bubble length in different conditions (p < 0.0001). The
length of the bubble was measured from fifteen bubbles for the analysis.
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